NTLA - Intellia Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NTLA is currently covered by 23 analysts with an average price target of $50.76. This is a potential upside of $35.33 (228.97%) from yesterday's end of day stock price of $15.43.

Intellia Therapeutics's activity chart (see below) currently has 146 price targets and 169 ratings on display. The stock rating distribution of NTLA is 73.13% BUY, 25.37% HOLD and 1.49% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.78% with an average time for these price targets to be met of 112.03 days.

Highest price target for NTLA is $85, Lowest price target is $19, average price target is $50.76.

Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 25-Oct-2024.

Currently out of the existing stock ratings of NTLA, 49 are a BUY (73.13%), 17 are a HOLD (25.37%), 1 are a SELL (1.49%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$20

$5.19 (35.04%)

$32

11 days ago
(25-Oct-2024)

4/6 (66.67%)

$4.05 (25.39%)

20

Hold

$19

$4.19 (28.29%)

$29

11 days ago
(25-Oct-2024)

3/6 (50%)

$3.05 (19.12%)

20

Buy

$54

$39.19 (264.62%)

$54

1 months 17 days ago
(19-Sep-2024)

2/6 (33.33%)

$31.07 (135.50%)

32

Buy

$64

$49.19 (332.14%)

$80

1 months 25 days ago
(11-Sep-2024)

0/4 (0%)

$43.76 (216.21%)

Buy

$55

$40.19 (271.37%)

$74

2 months 24 days ago
(12-Aug-2024)

0/4 (0%)

$33.23 (152.64%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NTLA (Intellia Therapeutics) average time for price targets to be met?

On average it took 112.03 days on average for the stock forecasts to be realized with a an average price target met ratio 41.78

Which analyst has the current highest performing score on NTLA (Intellia Therapeutics) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on NTLA (Intellia Therapeutics)?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 11 ratings on NTLA

Which analyst is the currently most bullish on NTLA (Intellia Therapeutics)?

Swapnil Malekar with highest potential upside - $148.19

Which analyst is the currently most reserved on NTLA (Intellia Therapeutics)?

Martin Auster with lowest potential downside - -$7.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?